全文获取类型
收费全文 | 28889篇 |
免费 | 2431篇 |
国内免费 | 109篇 |
专业分类
耳鼻咽喉 | 334篇 |
儿科学 | 824篇 |
妇产科学 | 575篇 |
基础医学 | 3419篇 |
口腔科学 | 769篇 |
临床医学 | 3102篇 |
内科学 | 6142篇 |
皮肤病学 | 436篇 |
神经病学 | 2660篇 |
特种医学 | 845篇 |
外国民族医学 | 2篇 |
外科学 | 4437篇 |
综合类 | 658篇 |
一般理论 | 34篇 |
预防医学 | 2563篇 |
眼科学 | 694篇 |
药学 | 1925篇 |
中国医学 | 35篇 |
肿瘤学 | 1975篇 |
出版年
2022年 | 223篇 |
2021年 | 502篇 |
2020年 | 314篇 |
2019年 | 502篇 |
2018年 | 545篇 |
2017年 | 436篇 |
2016年 | 411篇 |
2015年 | 535篇 |
2014年 | 715篇 |
2013年 | 1075篇 |
2012年 | 1603篇 |
2011年 | 1583篇 |
2010年 | 938篇 |
2009年 | 825篇 |
2008年 | 1438篇 |
2007年 | 1565篇 |
2006年 | 1576篇 |
2005年 | 1588篇 |
2004年 | 1478篇 |
2003年 | 1390篇 |
2002年 | 1370篇 |
2001年 | 545篇 |
2000年 | 474篇 |
1999年 | 532篇 |
1998年 | 357篇 |
1997年 | 303篇 |
1996年 | 320篇 |
1995年 | 265篇 |
1994年 | 223篇 |
1993年 | 212篇 |
1992年 | 390篇 |
1991年 | 328篇 |
1990年 | 357篇 |
1989年 | 308篇 |
1988年 | 314篇 |
1987年 | 300篇 |
1986年 | 268篇 |
1985年 | 267篇 |
1984年 | 263篇 |
1983年 | 261篇 |
1982年 | 251篇 |
1981年 | 232篇 |
1980年 | 236篇 |
1979年 | 257篇 |
1978年 | 203篇 |
1977年 | 174篇 |
1976年 | 175篇 |
1975年 | 158篇 |
1974年 | 171篇 |
1973年 | 147篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Lauren Tingey Britta Mullany Rachel Chambers Ranelda Hastings Angelita Lee Anthony Parker 《AIDS care》2015,27(9):1087-1097
Potential for widespread transmission of HIV/AIDS among American Indian (AI) adolescents exists, yet no evidence-based interventions (EBIs) have been adapted and evaluated with this population. Intensive psychoeducation may improve knowledge and decision-making which could potentially translate to reductions in HIV risk behaviors. A peer group randomized controlled comparison of an adapted EBI vs. control was delivered over an eight-day summer basketball camp in one reservation-based tribal community to adolescents ages 13–19. Outcome data were gathered immediately post-camp and at 6 and 12 months follow-up. Self-selected peer groups were randomized to intervention (n = 138) or control (n = 129) conditions for a total sample of 267 participants (56.2% female), mean age 15.1 years (SD = 1.7). Intervention participants had better condom use self-efficacy post-camp (Adjusted Mean Difference [AMD] = ?0.75, p < 0.005) and at 6 (AMD = ?0.44, p < 0.005) and 12 months (AMD = ?0.23, p < 0.05) follow-up. Intervention participants also had higher HIV prevention and transmission knowledge (post-camp: AMD = 0.07, p < 0.01; 6 months: AMD = 0.06, p < 0.01) were more likely to believe condoms prevent sexually transmitted infections (post-camp: RR = 1.41, p < 0.005; 6 months: RR = 1.34, p < 0.05), to talk with an adult about HIV/AIDS (post-camp: RR=1.78, p < 0.005; 6 months: RR = 1.14, p < 0.005), had higher partner negotiation efficacy related to substance use during sex (post-camp: AMD = 0.37, p < 0.01), and were more likely to intend to use a condom (post-camp: RR = 1.39, p < 0.01). The adapted intervention had short- and medium-term impacts on AI adolescent risk for HIV/AIDS, but attenuated at 12 months. Intervention delivery through a community-based camp is feasible and acceptable with strong retention. Additional study is needed to evaluate the adapted intervention's impact on sexual risk behaviors and if booster sessions and parent involvement translate to long-term impacts. 相似文献
2.
3.
Geneticists have, for years, understood the nature of genome‐wide association studies using common genomic variants. Recently, however, focus has shifted to the analysis of rare variants. This presents potential problems for researchers, as rare variants do not always behave in the same way common variants do, sometimes rendering decades of solid intuition moot. In this paper, we present examples of the differences between common and rare variants. We show why one must be significantly more careful about the origin of rare variants, and how failing to do so can lead to highly inflated type I error. We then explain how to best avoid such concerns with careful understanding and study design. Additionally, we demonstrate that a seemingly low error rate in next‐generation sequencing can dramatically impact the false‐positive rate for rare variants. This is due to the fact that rare variants are, by definition, seen infrequently, making it hard to distinguish between errors and real variants. Compounding this problem is the fact that the proportion of errors is likely to get worse, not better, with increasing sample size. One cannot simply scale their way up in order to solve this problem. Understanding these potential pitfalls is a key step in successfully identifying true associations between rare variants and diseases. 相似文献
4.
5.
PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease 下载免费PDF全文
6.
Implications for Practice
Breast cancer is far more curable than in the past but requires multimodality treatment. Great care must be taken to use the least leukemogenic treatment programs that do not sacrifice efficacy. Elimination of radiation and anthracycline/alkylating agent regimens will be helpful where possible, particularly in younger patients and possibly those with homologous repair deficiency (HRD). Use of colony-stimulating factors should be limited to those who truly require them for safe chemotherapy administration. Further study of a possible leukemogenic association with HRD and the various forms of colony-stimulating factors is badly needed.7.
8.
Daoyan Wei Henry Q. Xiong James L. Abbruzzese Keping Xie 《Journal of gastrointestinal cancer》2003,33(1):43-60
Pancreatic cancer is a lethal disease characterized by early metastasis, local invasion, and resistance to conventional therapies. To understand its etiology and eventually make prevention of it possible and effective, appropriate carcinogenesis models will certainly help us understand the effects of environmental and genetic elements on pancreatic carcinogenesis. The development of new treatment strategies to control cancer metastasis is of immediate urgency. Fulfillment of this task relies on our knowledge of the cellular and molecular biology of pancreatic cancer metastasis and the availability of biologically and clinically relevant model systems. Many of the existing pancreatic cancer carcinogenesis and metastasis animal models are described in this review. The advantages and disadvantages of each model and their clinical implications are discussed, and special attention is focused on experimental therapeutic strategies targeting pancreatic cancer metastasis. 相似文献
9.
10.